Overview
Updated 14 Jul 2026
Nikhil Munshi, MD, is Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute, Boston, MA. The public record shows 1,801 publications with 104,230 citations (h-index 152), centered on Multiple Myeloma. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 13 companies, 7 NIH-funded awards (2008–2025).
- Most recent indexed publication: 2026 · Blood cancer journal
- Top research focus: Multiple Myeloma
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 13 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 38 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomasociety.org ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
Sponsor: Travera Inc
InvestigatorTerminatedNCT03777410 - Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias
Sponsor: Boston VA Research Institute, Inc.
InvestigatorPhase 2CompletedNCT02041325 - Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Sponsor: Boston VA Research Institute, Inc.
InvestigatorPhase 2CompletedNCT01380106
Industry payments
Updated 14 Jul 2026
13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202510 payments$12,530openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20258 payments$11,591openpaymentsdata.cms.gov ↗
- Regeneron Pharmaceuticals, Inc.Program year20253 payments
NIH funding
Updated 14 Jul 2026
7 NIH research awards on record, funded 2008–2025 per NIH RePORTER. The latest:
- Multiscale functional characterization of genomic variation in human developmental disorders
Ut Southwestern Medical Center
FY2026$1,748,385UM1HG011996 - Interpreting coding/non-coding variants for congenital heart disease through gene regulatory networks
Ut Southwestern Medical Center
FY2026$786,708R01HL176998 - Developing vectors for potent and selective manipulation of cardiac rhythm
Ut Southwestern Medical Center
FY2026$535,934R01HL172898
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Editorial & leadership rolesjournal and society appointments
- Immediate Past President
International Myeloma Society (founding member and former Vice President)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myelomasociety.org ↗ - Member
Scientific Advisory Board, International Myeloma Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗ - Associate Director
Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomasociety.org ↗
Awards & honorshonors on the public record
- Robert A. Kyle Lifetime Achievement Award (Waldenström's Award)
International Myeloma Society, most distinguished lifetime achievement honor in myeloma research
2013verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myelomasociety.org ↗ - Lifetime Achievement Award
Association of VA Hematologists and Oncologists
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomasociety.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →myelomasociety.org ↗
Secondary affiliationsappointments beyond the home institution
- Attending Physician
VA Boston Healthcare System
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗ - Senior Physician
Brigham and Women's Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗ - Adjunct Associate Professor
Boston University Chobanian & Avedisian School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bumc.bu.edu ↗
Media & interviewspress, podcasts and appearances
- JCO Article Insights podcast
discussing IMS-IMWG Consensus Recommendations on Definition of High-Risk Multiple Myeloma
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopubs.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emjreviews.com ↗
- Video interview
VJHemOnc, on genomic instability, immunotherapy and molecular manipulation in multiple myeloma
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/scientific-contributions/Nikhil-C-Munshi-39747674
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/NikhilMunshiMD
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/dana-farber-cancer-institute_nikhil-c-munshi-md-activity-6584403982771384320-se-z
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Apple Podcasts
podcasts.apple.com/gb/podcast/nikhil-c-munshi-md-raising-the-bcma-standard-in/id208201754
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Other
myeloma.org/people/nikhil-munshi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myeloma.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Patrick Wen, MD
Dana-Farber Cancer Institute
- 1,915
- publications
- 146
- h-index
- 27
- trials
Geoffrey Shapiro, MD
Dana-Farber Cancer Institute
- 2,055
- publications
- 116
- h-index
- 24
- trials
Irene Ghobrial, MD
Dana-Farber Cancer Institute
- 1,124
- publications
- 101
- h-index
- 16
- trials
Patrick Ott, MD
Dana-Farber Cancer Institute
- 616
- publications
- 82
- h-index
- 8
- trials